SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-22-041828
Filing Date
2022-04-01
Accepted
2022-04-01 17:08:48
Documents
14
Period of Report
2022-01-13
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm229599d3_8ka.htm   iXBRL 8-K/A 28215
2 EXHIBIT 99.1 tm229599d3_ex99-1.htm EX-99.1 379524
  Complete submission text file 0001104659-22-041828.txt   662378

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA gls-20220113.xsd EX-101.SCH 3685
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gls-20220113_def.xml EX-101.DEF 27028
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE gls-20220113_lab.xml EX-101.LAB 37898
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gls-20220113_pre.xml EX-101.PRE 25650
8 EXTRACTED XBRL INSTANCE DOCUMENT tm229599d3_8ka_htm.xml XML 6340
Mailing Address 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116
Business Address 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116 857-327-7737
GELESIS HOLDINGS, INC. (Filer) CIK: 0001805087 (see all company filings)

IRS No.: 844730610 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39362 | Film No.: 22799311
SIC: 2834 Pharmaceutical Preparations